Key facts
- It has raised $12.4M; the latest was Later Stage VC ($1.8M) in Nov 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for BFKW
- ·The full record, as it builds
Funding rounds
No funding rounds for BFKW are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BFKW
Developer of bariatric devices designed to treat obesity by eliminating the need for gastric banding, gastric bypass, and intragastric balloon surgeries. The company's bariatric devices are implanted and extracted via endoscopy, induce satiety leading to significant weight loss, and offer a range of weight-reduction therapies, enabling patients to recover from obesity.
- Sector
- Healthcare
- HQ
- Ada, MI, United States
- Founded
- 2004
- Employees
- 4
- Website
- bfkw.org/
- Ownership
- Privately Held (backing)
BFKW doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BFKW shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BFKW in its N-PORT filings yet. We sweep new filings monthly.